• NBC19: NLRP3 Inflammasome Inhibitor Guide

  2026-09-09

  NBC19 is a NLRP3 inflammasome inhibitor with reported nanomolar activity in differentiated THP-1 cells. Product data report a 60 nM cellular IC50 and inhibition of Nigericin- and ATP-induced IL-1β release, making NBC19 a research tool for inflammasome and inflammation research.

• Methylprednisolone: Mechanism and Bone Evidence

  2026-09-09

  Methylprednisolone is a synthetic glucocorticoid receptor agonist with anti-inflammatory activity. A rat study used methylprednisolone to model glucocorticoid-induced osteonecrosis of the femoral head and measured bone, vascular, histologic, and osteoclast-related outcomes.

• Bestatin-Derived Inhibitors of IRAP and ERAP1

  2026-09-08

  The reference study establishes a stereoselective route for modifying the α-hydroxy-β-amino acid scaffold of Bestatin and identifies selective inhibitors of the M1 aminopeptidases IRAP, ERAP1, and ERAP2. Structural and cellular data show that interactions with the GAMEN loop, rather than zinc coordination alone, can drive low-nanomolar IRAP inhibition and substantial selectivity.

• Fumagillin Workflows for Angiogenesis Research

  2026-09-07

  Build reproducible Fumagillin assays for endothelial cell proliferation inhibition, tumor-induced angiogenesis studies, and comparative antiparasitic screening. This guide connects MetAP-2 biology with practical formulation, controls, readouts, and troubleshooting decisions.

• β-Elemene Inhibits Adipogenesis Through AMPK

  2026-09-07

  The reference study shows that β-Elemene suppresses MDI-induced lipid accumulation in 3T3-L1 cells, improves glucose consumption in a dexamethasone-induced insulin-resistance model, and restores AMPK pathway activity. Its main contribution is a cell-based mechanistic framework connecting a natural sesquiterpene with adipocyte differentiation and metabolic regulation, while also identifying the experiments needed to test whether AMPK is causally required.

• DMG-PEG2000-NH2: A Design Guide for TB Delivery

  2026-09-05

  DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid-platform engineering with rational antimycobacterial assay design. This guide explains its amide-coupling chemistry, formulation role, practical controls, and the translational limits of applying sulfonamide SAR insights to advanced delivery systems.

• Laminin (925-933): Practical Assay Guide

  2026-09-04

  This guide explains how to use Laminin (925-933) as a defined cell adhesion peptide in attachment, migration, and chemotaxis workflows. It focuses on product-dossier parameters, assay controls, solution handling, and interpretation limits; it should not be treated as evidence of broad therapeutic, in vivo, or metastasis-inhibitory activity.

• Phosphorylation as a Gatekeeper of BMAL1 Condensates

  2026-09-04

  BMAL1 phase separation links phosphorylation state to circadian transcription, creating a compelling use case for orthogonal dephosphorylation controls. This thought-leadership guide explains how Lambda Protein Phosphatase (RNase-free) can help translational researchers distinguish phosphorylation-dependent biology from antibody, protein integrity, and condensate-assay artifacts.

• RAFT Cationic Polymers for mRNA Delivery

  2026-09-04

  This study combines combinatorial RAFT polymerization, high-throughput biological screening, and machine learning to identify tertiary amine-containing methacrylate polymers for mRNA delivery. Its main contribution is a data-driven framework linking polymer and polyplex attributes with uptake, cytotoxicity, and transfection performance, while also highlighting the need for experimental validation of computational design rules.

• How to Measure Cancer Drug Responses In Vitro

  2026-09-03

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent dimensions of anticancer drug response. This framework supports better assay design, endpoint selection, and interpretation of time-dependent drug effects in cancer biology and mechanistic inhibitor studies.

• Gut Microbiota, RPE/Choroid, and AMD Pathobiology

  2026-09-02

  The 2022 reference study connects the absence of gut microbiota with RPE/choroid transcriptomic changes, smaller laser-induced choroidal neovascularization lesions, and reduced microglial infiltration in mice. Its combined RNA-sequencing and ocular angiogenesis model provides evidence for a gut–RPE/choroidal axis while also illustrating the RNA-to-cDNA workflow demands of transcriptomic research.

• CD8+ T Cell Metabolic Flexibility via CD28–ARS2

  2026-09-02

  The reference study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing and enables activated CD8+ T cells to adjust glucose catabolism. Its findings separate this splicing mechanism from canonical CD28–PI3K signaling and connect PKM2 enrichment with interferon-γ production and antitumor effector activity.

• Protein A/G Magnetic Beads: Practical Guide

  2026-09-01

  Protein A/G Magnetic Beads (K1305) provide Fc-directed capture of IgG antibodies for antibody purification, immunoprecipitation, co-IP, and Ch-IP workflows from complex biological samples. They should be used as research-use affinity particles, with antibody compatibility, bead loading, wash conditions, and elution conditions optimized for each assay rather than assumed from a universal protocol.

• Phosbind Biotin LC: PVDF Workflow Guide

  2026-09-01

  Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes using streptavidin-HRP and chemiluminescence. It is suited to Western Blot phosphorylated protein detection, but not to aqueous-only workflows, long-term storage of prepared solutions, or residue-specific phosphorylation assignments.

• Pifithrin-α (PFTα): A p53 Inhibitor Guide

  2026-08-31

  Pifithrin-α is a p53 inhibitor used to test p53-dependent apoptosis, growth arrest, and ferroptosis mechanisms. This guide connects product handling with evidence from a maternal deltamethrin neurotoxicity study while defining preclinical limits.

8761 records 2/585 page Previous Next 12345 下5页 Last page